LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Beth Altman Joins Alphatec Spine’s Board of Directors
Company News

Beth Altman Joins Alphatec Spine’s Board of Directors

August 27, 2021 1 min read Premium comments

Advertisement

#atec#alphatecholdingsSecondary#bethaltman

Beth Altman, former Managing Partner at KPMG LLP San Diego, has been appointed as an independent director to the Alphatec Holdings, Inc. (ATEC) Board of Directors and as chair of the Board’s Audit Committee. Donald A. Williams has resigned as an independent director and as Chair of the Audit Committee of the Board and member of its Finance Committee.

Altman, an audit partner with KPMG US for over 26 years, is also the former Managing Partner of the firm’s 300-person San Diego office. Her breadth of experience encompasses life science, consumer markets and technology sector expertise; she has also served as lead partner for many multinational public clients. She sits on the board of Allscripts and CV Sciences and “…was previously on the board of the Corporate Directors Forum, a 501(c)(6) nonprofit organization focused on helping Directors build more effective boards through continuous learning and peer networking.”

“We are thrilled to welcome Beth to the ATEC Board,” said Pat Miles, chairman and CEO. “Her breadth of business, accounting and finance insight and her passion for life science technologies will be essential as ATEC continues its evolution into a dominant spine company. We would also like to thank Don, one of ATEC’s longest-standing Board members, for his guidance and support throughout our ongoing business transformation.”

“I am excited to be part of the world class team and Board of Directors at ATEC,” Altman told OTW. “As Chair of the Board’s Audit Committee, I intend to leverage my depth of life science accounting and finance experience to contribute to the sophistication of ATEC’s financial practices and reporting as the company evolves into a dominant spine company.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy